Advertisement
UK markets open in 48 minutes

  • NIKKEI 225

    38,771.89
    +535.82 (+1.40%)
     

  • HANG SENG

    18,504.98
    -73.32 (-0.39%)
     

  • CRUDE OIL

    78.67
    +0.19 (+0.24%)
     

  • GOLD FUTURES

    2,328.30
    -2.90 (-0.12%)
     

  • DOW

    38,852.27
    +176.59 (+0.46%)
     

  • Bitcoin GBP

    50,637.37
    -548.68 (-1.07%)
     

  • CMC Crypto 200

    1,366.27
    +1.14 (+0.08%)
     

  • NASDAQ Composite

    16,349.25
    +192.92 (+1.19%)
     

  • UK FTSE All Share

    4,469.09
    +22.94 (+0.52%)
     

New GSK chairman backs CEO Witty to stay at helm

Reuters - UK Focus

LONDON, May 7 (Reuters) - GlaxoSmithKline (Other OTC: GLAXF - news) 's new chairman Philip Hampton expressed support for the company's current structure and its chief executive on Thursday while speaking to reporters after the drugmaker's annual meeting.

Hampton said he hopes CEO Andrew Witty will continue to run GSK for a good length of time, despite pressure from some shareholders for a change.

(Reporting by Ben Hirschler; Writing by Martinne Geller; Editing by David Goodman)